Background: The level of evidence regarding the association between red and processed meat intakes and breast cancer risk is still low, due to insufficient prospective studies. Moreover, mechanistic data suggest that some antioxidants may modulate this relationship but epidemiological evidence is lacking. Our objectives were to investigate relationships between red and processed meat intakes and breast cancer risk, and to study whether an antioxidant supplementation modulates these associations, which, to our knowledge, has never been investigated before. 
Introduction
Experimental studies support a pro-carcinogenic role of red and processed meat in the development of breast cancer. Indeed, these foods contain mutagenic by-products, such as heterocyclic amines [HCAs, among which the most prevalent are: 2-amino-1-methyl-6-phenylimidazo [4, 5-b] pyridine (PhIP)], polycyclic aromatic hydrocarbons (PAHs) and N-nitroso compounds (NOCs), resulting from meat processing or preparation, that stimulate mammary carcinogenesis in experimental studies. [1] [2] [3] [4] [5] [6] [7] [8] Red and processed meats are also important sources of the most bioavailable heme iron, which may contribute to initiate carcinogenesis via several mechanisms. [9] [10] [11] However, epidemiological evidence regarding the association between red and processed meat intakes and breast cancer risk is lacking. In the framework of the Continuous Update Project in 2010, the World Cancer Research Fund (WCRF) / American Institute for Cancer Research (AICR) stated that the available evidence was still insufficient to conclude regarding the associations between red or processed meat intakes and premenopausal or postmenopausal breast cancer risk. 12 A meta-analysis based on six case-control studies and four cohort studies among premenopausal women 13 suggested an increased breast cancer risk associated with red meat consumption. Another metaanalysis, 14 twhich included data from the Pooling Project (eight cohorts) and from 10 other cohorts, showed an increased breast cancer risk associated with processed meat intakes overall and with red meat intakes in postmenopausal women only. After these two meta-analyses, one prospective study was published and observed null associations between types of meat intake and breast cancer risk. 15 Thus, no consensus has been reached so far and new prospective studies are needed to more thoroughly elucidate the relationship between red and processed meat intakes and breast cancer risk.
In addition, other factors may interact with red and processed meat and thereby modulate their association with cancer risk, explaining contrasting results across epidemiological studies. Mechanistic data from animal models suggest that antioxidants may be good candidates for this modulatory role. Indeed, it has been shown that the addition of antioxidant to the diet (such as a-tocopherol or synthetic ascorbic acid derivatives) exert a chemopreventive action against PhIP-induced mammary carcinogenesis in rats. [16] [17] [18] However, to our knowledge, no prospective epidemiological study has previously investigated whether the associations between red and processed meat intakes and breast cancer risk are modulated by an antioxidant supplementation.
Thus, the objectives of this study were: (i) to prospectively investigate the association between red and processed meat intakes and breast cancer risk; and (ii) to assess the potential modulatory effect of an antioxidant supplementation on these relationships.
Methods

Study population
double-blind, placebo-controlled, randomized trial (Trial Registration clinicaltrials.gov Identifier: NCT00272428) initially designed to assess the effect of a daily antioxidant supplementation on the incidence of cardiovascular disease and cancer. 19 A total of 13 017 subjects were enrolled in 
Baseline data collection
At enrolment, self-administered questionnaires were filled in by participants about socio-demographics(date of birth, educational level), smoking status, medication use including baseline use of hormonal treatment for menopause (HTM), number of live births, family history of breast cancer and menopausal status. Baseline physical activity was self-evaluated by asking the participants if they currently practised a regular physical activity and, if yes, if it was equivalent to 1 h/day of walking or less. Anthropometric measurements were taken during a baseline clinical examination. Weight was measured with an electronic scale (Seca, Hamburg, Germany) by study nurses and physicians for subjects in light clothing and with no shoes to the nearest 0.1 kg, and height was measured to the nearest 1 cm with a wall-mounted stadiometer in the same conditions. During the follow-up period, participants were invited to complete a dietary record every 2 months, in which they declared all foods and beverages consumed during periods of 24 h. These dietary records were randomly distributed between week and weekend days and over seasons to take into account intra-individual variability. Dietary records from the first 2 years of follow-up were used in the present study to comply with the prospective design. Completion was made through the Minitel Telematic Network, a French telephone-based terminal equivalent to an internet prototype. Portion sizes were assessed thanks to a validated picture booklet 21 and the amounts consumed from composite dishes were estimated using French recipes validated by food and nutrition professionals. The mean daily energy, alcohol and nutrient intakes were estimated using a published French food composition table. 22 Subjects were advised against taking any self-prescribed dietary supplements during their participation in the SU.VI.MAX study. Dietary exposure variables considered in the present analysis were total daily intake of red meat and processed meat in g/day. Red meat consisted of fresh, minced and frozen beef, veal, por, and lamb. Processed meats were mostly pork and beef preserved by methods other than freezing, such as salting, smoking, marinating, air-drying or heating and included ham, bacon, sausages, blood sausages, liver pâté, salami, mortadella, tinned meat and others.
Case ascertainment
Health events occurring during the follow-up were selfreported by participants. Medical data were then gathered from participants, physicians and/or hospitals and reviewed by an independent physician expert committee. Pathological reports were used to validate the cases and to extract cancer characteristics (histological type, estrogen and progesterone receptors, tumour size, number of nodes, cancer grade). Cases were classified using the International Chronic Diseases Classification, 10th Revision, Clinical Modification (ICD-10). 23 All first incident primary breast cancers were considered as cases in this study.
Statistical analyses
From among the 7876 female participants in the SU.VI.MAX study, we excluded 120 women who reported a cancer diagnosis before the start of the follow-up. Among the remaining subjects, 4684 provided at least three valid dietary records within the first 2 years of follow-up and thus remained available for analysis. For overall breast cancer analysis, women contributed person-time until the date of diagnosis of breast cancer, the date of last completed questionnaire, the date of death or September 2007, whichever occurred first. Women who reported a cancer other than breast cancer (N ¼ 164) during the study period were included and censored at the date of diagnosis (except basal cell skin carcinoma, not considered as cancer). Nutrient intakes were estimated by the average intake calculated from all dietary records for each woman. The participants' baseline characteristics were compared between cases and non-cases using Student's t tests or v 2 tests. Hazards ratios (HRs) and 95% confidence intervals (CIs), obtained from Cox proportional hazards models with age as the primary time variable, were used to characterize the association between quartiles of red and processed meat and incident breast cancer risk.
Since cooked ham generally presents specific (better) nutritional qualities than other processed meats (less rich in energy, lipids and salt, 22 with very low-to-undetectable levels of HCAs), 24 we also tested a model considering processed meat excluding cooked ham, as done previously. 25 Tests for linear trend were performed using the ordinal score on quartiles of red and processed meat intakes. Minimally adjusted models were controlled for age as time-scale, intervention group of the SU.VI.MAX trial (antioxidant supplementation/placebo) and number of dietary records (continuous). Fully adjusted multivariate models included the same variables, to which were added the following: smoking status (never, former or current), educational level (primary, secondary or university), physical activity (irregular, <1 h/d or 1 h/d walking or equivalent), height (continuous), body mass index (BMI; continuous), without alcohol energy intake (continuous), alcohol intake (continuous), total lipid intake (continuous), family history of breast cancer (yes/no), number of live births (continuous), menopausal status at baseline (yes/no), use of HTM at baseline (yes/no), and mutual adjustment for red and processed meat intakes (quartiles).
Further adjustments for fruit and vegetable intakes and for an overall healthy dietary pattern that was positively correlated with vegetable, fruit, and seafood intakes were also tested. This healthy pattern was extracted by principal component analysis, using the SAS 'proc factor' procedure, from mean intakes of 31 food groups. 26 There was no missing datum for covariates except for smoking status, physical activity and educational level for which missing values (less than 5% for each variable) were replaced by the modal value. Interaction between antioxidant supplementation (yes/no) and red or processed meat intakes (quartiles) was tested by introducing an interaction term into the models (product of the two variables). Analyses were conducted overall and then stratified by antioxidant supplementation group of the SU.VI.MAX trial. Associations were also examined after stratification by total intake of fruits and vegetables (< vs median, i.e. 346.75 g/day), within the placebo group. Models were also computed separately for premenopausal and postmenopausal breast cancers (women contributed to the premenopausal model until their age of menopause, and conversely, women contributed to the post-menopausal model from their age of menopause). All tests were twosided. SAS version 9.3 (SAS Institute, Cary, NC) was used for analyses.
Results
During a median follow-up of 11.3 years (52 943 personyears), 190 women developed a first primary breast cancer (59 premenopausal and 131 postmenopausal) with a mean age at diagnosis of 55.8 years. Among breast cancers, 82% were estrogen receptor positive (ERþ) and 86% were progesterone receptor positive (PRþ). Regarding histological type of breast cancers, 67% were ductal, 16% were lobular and 17% derived from other types. Mean tumour size was 16.6 mm ( 6 13.3 mm). In our study population, 2.8% of the women were lost to follow-up (5.2% in the overall SU.VI.MAX trial). Table 1 presents baseline characteristics of the subjects. Compared with non-cases, breast cancer cases tended to be older, taller, to have more family history of breast cancer, to be more often menopausal and to use HTM more often. Processed meat intake was associated with increased breast cancer risk in premenopausal women (59 cases/ 3271 women, P trend ¼ 0.03 for processed meat and P trend ¼ 0.009 for processed meat excluding ham) but not in postmenopausal women (131 cases/3532 women, P trend ¼ 0.2 for processed meat and P trend ¼ 0.07 for processed meat excluding ham) (data not shown).
Although no statistical interaction was detected between red and processed meat intakes and supplementation group on breast cancer risk, differences were observed in stratified analyses ( Consistently, when analyses were stratified by fruit and vegetable intake within the placebo group, we observed an increased breast cancer risk with processed meat intake excluding cooked ham in lower (P trend ¼ 0.03) but not in higher (P trend ¼ 0.07) fruit and vegetable consumers.
Similar results were observed when models were adjusted for baseline dietary antioxidant intakes (the same as those contained in the capsule): HR Q4vs.Q1 for processed meat intake was 1.39 (95% CI 0.88-2.19) (P trend ¼ 0.05) and HR Q4vs.Q1 ¼ 1.84 (95% CI 1.14-2.97) (P trend ¼ 0.009) for processed meat excluding cooked ham. Processed meat intake was associated with increased breast cancer risk in the placebo group only [HR Q4vs.Q1 ¼ 2.41 (95% CI 1.25-4.64), P trend ¼ 0.002], but not in the antioxidant-supplemented group (P trend ¼ 0.6) (P for interaction ¼ 0.06). The results were similar for processed meat excluding cooked ham [HR Q4vs.Q1 ¼ 2.32 (95% CI 1.22-4.42), P trend ¼ 0.004 in the placebo group and P trend ¼ 0.5 in the supplemented group]. Further adjustments for fruit and vegetable intake or for an overall healthy dietary pattern did not substantially modify the findings (data not shown). Sensitivity analyses excluding breast cancer cases diagnosed within the first 2 years of follow-up did not modify the findings (165 cases/ 4659 women), nor did sensitivity analyses focusing only on invasive breast cancers (167 cases/4661 women), or focusing on women without family history of breast cancer (159 cases/4277 women), or focusing on women who declared having taken at least two thirds of the capsules during the trial (153 cases/3652 women). Likewise, results were unchanged when considering only women who completed more than six dietary records during the first 2 years of follow-up (158 cases/3771 women). We also performed analyses considering red and processed meat intakes as time-dependent variables with one averaged value of intake per 2 years of follow-up (185 cases/4725 women). Again, this did not modify our findings: processed meat intake was associated with increased breast cancer risk in the placebo group [HR Q4vs.Q1 ¼ 2.03 (95% CI 1.10-3.76), P trend ¼ 0.01], but not in the antioxidant-supplemented group (P trend ¼ 0.4). 102 cases / 2367 women in the placebo group and 88 cases / 2317 women in the supplemented group. Model 1 is adjusted for age (time scale) and number of dietary records. Model 2 is adjusted for age (time scale), number of dietary records, smoking status, educational level, physical activity, height, BMI, family history of breast cancer, menopausal status at baseline, use of HTM at baseline, number of live births, without-alcohol energy intake, alcohol intake, total lipid intake. In addition, the red meat model is adjusted for processed meat intake and conversely (mutual adjustment).
Cut-offs (g/d) for quartiles of intakes were 24.9/42.5/63.7 for red meat, 16.4/28.6/43.5 for processed meat and 8.7/18.8/33.1 for processed meat excluding cooked ham.
Discussion
In this prospective study, processed meat intake was directly associated with breast cancer risk. In addition, to our knowledge, this study was the first to prospectively examine the potential modulatory role of an antioxidant supplementation on the relationships between red and processed meat intake and breast cancer risk. Interestingly, we observed an increased breast cancer risk associated with processed meat intake in the placebo group but not in the antioxidant-supplemented group.
The meta-analysis of Alexander et al., 14 based on prospective studies, also detected a direct association between processed meat intake and breast cancer risk. In contrast, in the prospective Black Women's Health Study 15 published after this meta-analysis, no association between processed meat intake and breast cancer risk was observed.
A wide array of factors may explain different results across prospective studies: methods of dietary assessment, exposure definition (food groups, serving sizes), exposure contrasts (analytical cut-points and comparisons of intake levels) and adjustment for potential confounders. Our baseline intakes fell within the upper range of European values for red meat (24-57 g/day) and processed meat (5-49 g/day). 27 Compared with US values (53 g/d for red meat and 18 g/d for processed meat), 28 red meat intake was slightly lower but intake of processed meat was higher in our study. This wide range of processed meat intake strengthened our ability to detect some association with breast cancer risk. Conversely, the fact that no association was observed with red meat intake in this study may be explained by intake values that were too low to properly investigate any adverse effect. Indeed, the cut-off for quartile 4 of red meat intake was 63.7 g/d, i.e. about 445 g/week, which is lower than the upper dose recommended in colorectal cancer prevention (500 g/week according to the WCRF 29 ). Our observation of an increased association between processed meat and breast cancer before but not after menopause is in favour of an estrogenic effect and/or a reduction of the time to cancer diagnosis due to DNA damage effects. Our result is consistent with the observation in the Nurses' Health Study II of a positive association between red and processed meat consumption during adolescence and premenopausal cancer, which was more pronounced in hormone-positive tumours. 30 One of the most salient and original findings of our study is the fact that an antioxidant supplementation modulated the association between processed meat intake and breast cancer risk. Besides, in the placebo group, we also observed an increased breast cancer risk with processed meat intake excluding cooked ham in lower but not in higher fruit and vegetable consumers. This suggests that dietary (and not only supplemental) antioxidants may also modulate the association between processed meat intake and breast cancer risk. Consistently with this last finding, previous studies suggested an effect modification of fruit and vegetable intakes (sources of antioxidants) on the relationship between cooked meat 31 or meat-derived product mutagenic intakes and breast cancer risk. 32 Biological plausibility supports a pro-carcinogenic effect of processed meat on breast tumour development. First, processed meat is rich in saturated fat that has been associated with increased breast cancer risk in epidemiological studies. 33 Second, high-temperature cooking methods produce compounds such as HCAs (including PhIP) and PAHs 34, 35 which have been associated with mammary tumour development in animal 2-4 and human [36] [37] [38] [39] [40] [41] studies.
These compounds exert a pro-carcinogenic effect through direct DNA damage (formation of DNA adducts) and possibly via other mechanisms such as estrogenic properties of PhIP. 31, 42 Third, another group of potential carcinogens in processed meat are NOCs, partly resulting from the endogenous reaction of nitrite (added as preservatives in processed meat) with other nitrosation precursors such as amines and amides. [5] [6] [7] Last, processed meat contains high levels of heme that catalyzes the endogenous formation of NOCs and the peroxidation of dietary fats. [9] [10] [11] Mechanistic data also support the observed modulatory role of an antioxidant supplementation in the association between processed meat intake and breast cancer risk. In animal models, it has been shown that the addition of antioxidants to the diet, including a-tocopherol, may exert a chemopreventive action against PhIP-induced mammary carcinogenesis. 16, 18 Interestingly, these results are consistent with experimentations conducted on another cancer site, i.e. the colon. Indeed, Pierre et al. 43 showed that antioxidant supplementation inhibited the haemin-induced aberrant crypt foci promotion in rats. The same team recently showed that dietary a-tocopherol suppressed cured-meat promotion of chemically induced carcinogenesis in rats and reduced associated biomarkers in human volunteers. 44 The observed interaction between processed meat (but not red meat) and antioxidants guides the interpretation towards the putative pro-carcinogenic mechanisms that are more likely to be reversed by antioxidants, such as those involving NOCs and peroxidation processes. Indeed, vitamin C and other antioxidants such as vitamin E and some carotenoids, can inhibit endogenous NOC formation 45 and modulate the association between NOC and cancer risk. 46 Experimental studies also showed that antioxidants can protect fatty acids from peroxidation. 47 Contrary to red meat, processed meat is a source of nitrate and nitrites, precursors of NOCs. 1 Processed meat is also richer than red meat in peroxidable lipids. This could explain why we observed results for processed meat but not for red meat. Strengths of this study included its prospective design, the wide range of potential lifestyle and dietary confounding factors taken into account, and the originality of the hypothesis tested, i.e. for the first time in an epidemiological study, the investigation of a potential modulatory role of an antioxidant supplementation in the association between red and processed meat intakes and breast cancer risk.
Some limitations should be acknowledged. First, although the number of breast cancer cases was reasonably large overall, it did not allow us to investigate separately the different histological and receptor types of breast cancers 30 and polymorphisms of enzymes involved in the metabolism of genotoxic compounds and estrogens. 42, 48, 49 Besides, statistical power was not sufficient to simultaneously stratify analyses by antioxidant supplementation group and menopausal status. Nevertheless, even if our ability to detect some of the hypothesized observations may have been limited by the number of cases, this limitation is unlikely to explain the observed relationships. An initial power analysis indicated that with a ¼ 5% and Power (1-b) ¼ 80%, our data allowed the detection of an effect (HR)0.5 or 1.8 among the placebo group and 0.4 or 1.9 among the intervention group. These effect sizes correspond to those expected in this field of nutritional epidemiology. Second, even if the number of lostto-follow-up women was very low (2.8%), they tended to be younger, to be less often menopausal, to use HTM less often and to have had fewer live births, compared with women who remained in the study. Third, since participants received a combination of antioxidants, it was not possible to identify whether one of them was more particularly involved in the studied modulation. However, it can be postulated that a-tocopherol may have played a central role, as previously suggested. 16, 44 Last, information about spontaneous use of dietary supplements (other than the intervention capsule) was not available. However, subjects were monthly advised against such practices during the trial. Besides, compliance with the trial protocol was high 19 and was similar in the supplemented and the placebo groups (mean percentage of capsule taken ¼ 84% in each group).
In conclusion, this prospective study suggests that processed meat intake, but not red meat intake, is associated with increased breast cancer risk, in line with experimental data. This study also suggests that supplemental (and possibly dietary) antioxidants may modulate this association by counteracting the potential pro-carcinogenic effects of processed meat on breast cancer. To our knowledge, this potential modulatory role of an antioxidant supplementation in the relationship between red and processed meat intakes and breast cancer risk has never been investigated before in any prospective epidemiological study. Literature regarding beneficial or harmful effects of antioxidant supplementation on cancer risk is contrasted, 50 and our study adds to the current debate on this topic. Further research is needed to gain more insights into the effects of red and processed meat intakes on breast carcinogenesis and into the potential effect-modifier role of individual or combined antioxidants (from supplements and diet) in this relationship.
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